MALAYSIAN STATISTICS ON MEDICINES 2015-2016 Edited by Mary Chok Chiew Fong, Azzy Iyzati Ahmad Shanizza A publication of the Pharmaceutical Services Programme Ministry of Health Malaysia February 2020 Ministry of Health Malaysia Published by Pharmaceutical Services Programme Ministry of Health Malaysia Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia. Telephone (603) 7841 3200 Fax (603) 7968 2222 Website www.pharmacy.gov.my This report is copyrighted. Reproduction and dissemination of this report in part or in whole for research, educational or other non-commercial purposes are authorised without any prior written permission from the copyright holders provided the source is fully acknowledged. Suggested citation: Malaysian Statistics on Medicines 2015-2016; Pharmaceutical Services Programme, Ministry of Health Malaysia: Kuala Lumpur, 2020. Funding : The study on medicines utilisation and publication of Malaysian Statistics on Medicines were funded by Pharmaceutical Services Programme, Ministry of Health Malaysia. ii PREFACE Enhance the accessibility of affordable and equitable medicines, and promote rational use of safe and effective medicines in Malaysia are integral of the implementation of Malaysian National Medicines Policy (NMP). Govern by the policy, it is therefore essential to deliver pharmaceutical services of high quality and efficiency to the nation as a single entity by all stakeholders, irrespective of either in public or private sector to improve health status and quality of life of Malaysian population. Thus, Pharmaceutical Services Programme has been the pioneer in conducting several initiatives to achieve the ultimate goals of NMP. National medicines utilisation study and publication of Malaysian Statistics on Medicines (MSOM) are example of these initiatives to support NMP. Most current, up-to-date findings in MSOM may serve as valuable resources for better decision making in areas of higher priority or unmet needs and financial concerns in healthcare system. Since the release of MSOM 2011-2014 in 2018, considerable effort has been taken in improving the methodology of medicines utilisation study in the subsequent years of study. This including the formation of a technical advisory committee, a platform designated for discussion and sharing of information and experiences. In addition, methods on data collection and processing has been revised and improved further to acquire high quality data. This is crucial for the publication of current, accurate and reliable statistics on time for use by health professionals. In this report, the tabulation of findings was further refined by including groups of medicines which was not previously included in MSOM 2011-2014. For the purpose of enabling meaningful comparison with statistics published in the past, same analysis method was applied. We sincerely hope that MSOM 2015-2016 would provide valuable information to all fields of healthcare professionals, and could serve as a source of reference and baseline for embarking in future research or clinical audits towards promoting rational prescribing and effective medicines use. We are grateful to all colleagues and collaborators who had worked very hard in ensuring the success of this report. These including all agencies, institutions, expert panel members and all individuals who had contributed invaluable input. In the spirit of true cooperation and partnership in research and development, the value of rational use of medicines and attaining high quality healthcare status of the nation can be uphold. Pharmaceutical Services Programme Ministry of Health Malaysia iii ACKNOWLEDGEMENTS Team members of national medicines utilisation study would like to express highest gratitude to all the individuals involved, directly or indirectly in making the study on medicines utilisation and publication of MSOM 2015-2016 a success. This gratitude would go to . Senior Director of Pharmaceutical Services Programme, Ministry of Health Malaysia for the invaluable support in conducting research, . Director of Pharmacy Policy and Strategic Planning Division, Ministry of Health Malaysia for the support in providing resources and advice on implementing medicines utilisation study and publication of this report, . Deputy Director and pharmacists at Medicines Pricing Branch, Pharmacy Practice and Development Division, Ministry of Health Malaysia, of their generosity in data sharing required for this project, . Deputy Director and pharmacists at Pharmacy Logistics Branch, Pharmacy Practice and Development Division, Ministry of Health Malaysia, of the precious, . Personnel at Pharmaniaga Logistics Sdn Bhd, who had contributed diligently to the study, . IQVIA Solution Malaysia Sdn Bhd, for the valuable inputs, . All the members of the expert panel who had contributed to the review and writing of this report, . All participating pharmacist personnel at Pharmacy Departments in Ministry of Health Malaysia, and at three university hospitals in the Ministry of Education Malaysia, . Reviewers and members of Technical Advisory Committee for their extensive review and valuable comments on the project and report, . All individuals who had in one way or another contributed enthusiastically to the success of this project. Lastly, the team would like to thank the Director General of Health Malaysia for the permission to publish this report. iv Project Team of National Medicines Utilisation Study Leader Dr. Azuana Ramli Deputy Director Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia Coordinator Mr. Tineshwaran Velvanathan Pharmacist Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia Mdm Azzy Iyzati Ahmad Shanizza Research Officer Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia Mdm Chan Lai Yue Pharmacist Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia Statistician Ms. Mary Chok Chiew Fong Pharmacist Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia Research Assistant Ms. Safura Sa’ad Research Officer Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia Ms. Noor Atiqah Mat Yusoff Research Officer Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia Mr. Mohd Faiz Abdul Manan Research Officer Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia Reviewers of Malaysian Statistics on Medicines 2015-2016 Mdm Norazlin A. Kadir Pharmacist Pharmacy Practice and Development Division Ministry of Health Malaysia Mdm Hazimah Hashim Pharmacist Pharmacy Practice and Development Division Ministry of Health Malaysia Mdm. Haarathi Chandriah Pharmacist Pharmacy Practice and Development Division Ministry of Health Malaysia v Technical Advisory Committee of National Medicines Utilisation Study Chairperson Dr. Hasenah Ali Director Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia Co-chairperson Dr. Roshayati Mohamad Sani Director Pharmacy Practice and Development Division Ministry of Health Malaysia Secretary Dr. Azuana Ramli Deputy Director Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia Member Mdm Nur’Ain Shuhaila Shohaimi Deputy Director Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia Mdm Wan Utma Sapini Wan Abdul Samad Pharmacist Pharmacy Practice and Development Division Ministry of Health Malaysia Mdm Norazlin A. Kadir Pharmacist Pharmacy Practice and Development Division Ministry of Health Malaysia Mdm Rosliza Lajis Pharmacist Pharmacy Practice and Development Division Ministry of Health Malaysia Ms. Nor Hasni Haron Pharmacist Pharmacy Practice and Development Division Ministry of Health Malaysia Ms. Teoh Iyinh Theng Pharmacist Pharmacy Policy and Strategic Planning Division Ministry of Health Malaysia vi Members of Expert Panel CARDIOLOGY Dr. Abd Kahar Abd Ghapar Dr. Amin Ariff Nuruddin Head of Department & Senior Consultant Senior Consultant Cardiologist Cardiologist National Heart Institute Serdang Hospital Dr. Azhari Rosman Prof Dr. Omar Ismail Senior Consultant Cardiologist Consultant Cardiologist National Heart Institute Universiti Islam Antarabangsa Sultan Abdul Halim Mu’adzam Shah Prof Dr. Wan Azman Wan Ahmad Dr. Wardati Mazlan Kepli Consultant Cardiologist Pharmacist University Malaya Medical Centre Serdang Hospital Mdm Nirmala Jagan Mr. Jivanraj Nagarajah Pharmacist Pharmacist Kuala Lumpur Hospital Kuala Lumpur Hospital DERMATOLOGY Dr. Suganthi Thevarajah Dr. Preamala Gunabalasingam Head of Department & Senior Consultant Head of Department & Consultant Dermatologist Dermatologist Kuala Lumpur Hospital Melaka Hospital Dr. Tang Min Moon Consultant Dermatologist Kuala Lumpur Hospital ENDOCRINOLOGY Dr. Zanariah Hussein Dr. Nor Afidah Karim Senior Consultant Endocrinologist & Physician Endocrinologist & Physician Putrajaya Hospital Tuanku Ja’afar Hospital, Seremban Dr. Vijiya Mala Valayatham Dr. Danish Ng Ooi Yee Endocrinologist & Physician Endocrinologist & Physician Putrajaya Hospital Selayang Hospital Dr. Wong Hui Chin Dr. Navin Kumar Loganadan Endocrinologist & Physician Pharmacist Tengku Ampuan Rahimah Hospital, Klang Putrajaya Hospital Mdm Daphne Gima Pharmacist Putrajaya Hospital GASTROENTEROLOGY AND HEPATOLOGY Dr. Rosaida Md Said Dr. Tan Soek Siam Senior Consultant Gastroenterologist & Senior Consultant Gastroenterologist & Hepatologist Hepatologist Ampang Hospital Selayang Hospital Dr. Muhammad Radzi Abu Hassan Dr. Zalwani Zainuddin Senior Consultant Gastroenterologist